<!DOCTYPE html>
<html>
<head>
    <title>PressReader - The Straits Times: 2020-10-13 - In&#xAD;done&#xAD;sia aims to start ad&#xAD;min&#xAD;is&#xAD;ter&#xAD;ing Covid-19 vac&#xAD;cines next month</title>
    <meta name="description" content="">
    <meta content="magazines, newspapers, digital news, reading, news, breaking news, newspaper online" name="keywords">
    <meta name="Robots" content="NOARCHIVE,NOODP">
    <meta charset="UTF-8">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    
    <link rel="canonical" href="/singapore/the-straits-times/20201013/281711207119765" />


    <style>
        li {
            margin: 1em 0;
        }
        img {
            max-width: 100%;
        }
        p, h1, h2, h3 {
            max-width: 100%;
        }
    </style>
</head>
<body>
    <div>
        

<article>
    <h1>In&#xAD;done&#xAD;sia aims to start ad&#xAD;min&#xAD;is&#xAD;ter&#xAD;ing Covid-19 vac&#xAD;cines next month</h1>
    <h2></h2>
    <section>
        <a href="/singapore/the-straits-times/textview" title="The Straits Times">The Straits Times</a>
        - <a href="/singapore/the-straits-times/20201013/textview" title="The Straits Times - 2020-10-13"><time>2020-10-13</time></a>
        - <span>WORLD</span>
        - <span role="byline">Wahyudi So&#xAD;e&#xAD;ri&#xAD;aat&#xAD;madja In&#xAD;done&#xAD;sia Cor&#xAD;re&#xAD;spon&#xAD;dent In Jakarta wahyudis@sph.com.sg</span>
    </section>

    <p>In­done­sia is aim­ing to start ad­min­is­ter­ing coro­n­avirus vac­cines early next month by re­ly­ing on sup­ply from Chi­nese drug­mak­ers as the world’s fourth-most pop­u­lous coun­try fights a health cri­sis that may re­sult in its first re­ces­sion in more than two decades.</p>
    <p>The Co­or­di­nat­ing Min­istry for Mar­itime and In­vest­ment Af­fairs yes­ter­day said 100,000 doses will be sup­plied by CanSino Biolog­ics, the first Chi­nese com­pany to test a Covid-19 vac­cine on hu­mans, next month.</p>
    <p>Si­novac Biotech, a China-based com­pany, will be sup­ply­ing three mil­lion doses by De­cem­ber. The firm has been work­ing with In­done­sia’s state-owned phar­ma­ceu­ti­cal com­pany Bio Farma since April on a Covid-19 vac­cine.</p>
    <p>An­other five mil­lion doses will come, start­ing next month, from a part­ner­ship be­tween Chi­nese state-owned phar­ma­ceu­ti­cal com­pany Sinopharm and United Arab Emi­rates tech­nol­ogy com­pany G42.</p>
    <p>The three vac­cines, which are un­der­go­ing third and fi­nal phase clin­i­cal tri­als, have re­ceived emer­gency use au­tho­ri­sa­tion from China, the min­istry said in a state­ment.</p>
    <p>“Health work­ers, paramedics, pub­lic of­fi­cials, mil­i­tary and po­lice of­fi­cers, teach­ing staff at all lev­els will be the first to re­ceive the vac­cines,” Health Min­is­ter Ter­awan Agus Pu­tranto added in the state­ment.</p>
    <p>In­done­sia started train­ing health of­fi­cials at com­mu­nity clin­ics to ad­min­is­ter Covid-19 vac­cines from late last month.</p>
    <p>Dr Ter­awan said the vac­cines would be avail­able for sale later but would re­main free for low-in­come groups.</p>
    <p>The state­ment fol­lows a trip to Kun­ming, China, last week by high­rank­ing of­fi­cials from In­done­sia. The del­e­ga­tion in­cluded Dr Ter­awan, the head of the coun­try’s food and drug agency Dr Penny K.</p>
    <p>Luk­ito, Bio Farma’s pres­i­dent di­rec­tor Hon­esti Basyir, and Mr Luhut Pandjaitan, the Co­or­di­nat­ing Min­is­ter for Mar­itime and In­vest­ment Af­fairs.</p>
    <p>Mr Luhut, who was ap­pointed by Pres­i­dent Joko Wi­dodo last month to lead the Covid-19 fight in In­done­sia, held a meet­ing with Chi­nese For­eign Min­is­ter Wang Yi.</p>
    <p>The visit saw China and In­done­sia an­nounce agree­ments to work on Covid-19 vac­cine re­search, pro­duc­tion and dis­tri­bu­tion.</p>
    <p>Last Satur­day, Mr Luhut quoted Mr Wang as de­scrib­ing In­done­sia as hav­ing the strong­est ca­pac­ity for vac­cine pro­duc­tion in South-east Asia.</p>
    <p>Bio Farma, which pro­duces po­lio and BCG vac­cines, pri­mar­ily used against tu­ber­cu­lo­sis, will start Covid-19 vac­cine pro­duc­tion next month.</p>
    <p>The Si­novac-Bio Farma vac­cine is based on an in­ac­ti­vated whole virus, a ma­ture vac­cine tech­nol­ogy that has been used to pro­duce vac­cines against in­fluenza and po­lio.</p>
    <p>In con­trast, many phar­ma­ceu­ti­cal com­pa­nies are work­ing on nextgen­er­a­tion plat­forms that in­volve us­ing the DNA or RNA of the coro­n­avirus that causes Covid-19.</p>
    <p>If the on­go­ing trial is suc­cess­ful, Bio Farma plans to ramp up pro­duc­tion to its max­i­mum ca­pac­ity of 250 mil­lion doses a year.</p>


</article>

<section>
    <h3><a href="/catalog/language/english">Newspapers in English</a></h3>
    <h3><a href="/catalog/country/singapore">Newspapers from Singapore</a></h3>
</section>

    </div>
    
    <p><a href="http://www.pressreader.com">© PressReader. All rights reserved.</a></p>

        <script>
            (function (i, s, o, g, r, a, m) {
                i['GoogleAnalyticsObject'] = r; i[r] = i[r] || function () {
                    (i[r].q = i[r].q || []).push(arguments);
                }, i[r].l = 1 * new Date();
                a = s.createElement(o), m = s.getElementsByTagName(o)[0]; a.async = 1; a.src = g;
                m.parentNode.insertBefore(a, m);
            })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
        </script>
        <script>
            ga('create', 'UA-44408245-1');
            ga('send', 'pageView');
        </script>
</body>
</html>
